HR-Positive Breast Cancer: Anna's Survivor Story
This breast cancer diagnosis at a glance
- Biomarkers
- ER-positive, PR-positive and HER2-positive (triple-positive)
- Sex
- Female
- Treatment
- surgery, chemotherapy, radiation and hormone therapy
- Outcome
- Treatment Completed / Survivorship
Treatment course, step by step
- Lumpectomy → chemotherapy → radiation → hormone therapy that induced menopause at age 37.
What happened, in summary
Anna found a breast lump on her 37th birthday. Her gynecologist initially did not consider it urgent, but Anna pushed for further testing. Because she had dense breast tissue, ultrasound was important in identifying the tumor, and a biopsy confirmed triple-positive breast cancer. At the time, her son was 2½ years old and she and her husband were considering another child.
Anna underwent a lumpectomy followed by chemotherapy, radiation and hormone therapy. Hormone treatment caused menopause at 37 and sharply changed her fertility plans. She described loving the child she already had while also grieving the loss of the possibility of another biological child.
The emotional effects continued after visible treatment ended. Anna developed depression and suicidal thoughts and eventually sought therapy and antidepressant treatment with support from her husband. Photography became a way to document the physical and emotional changes, and the project later developed into a book created with her husband.
In survivorship, Anna emphasized that recovery does not end when hair grows back or appointments become less frequent. She had completed active treatment, but emotional healing, fertility grief and adjustment to early menopause remained part of her cancer experience.
Where this story comes from
This is a lay summary of an account first published by The Patient Story. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer